Skip to main content
Premium Trial:

Request an Annual Quote

Here's a Thought: Safety and Caution in Biohazard Research

The Effect Measure blog offers a post arguing that all this increased spending on biodefense -- and the dangerous microbes that go along with it -- should come with a spending boost for oversight of this field, too. "The fact is there is no reliable surveillance for laboratory acquired infections and we have no real assurance workers have not become seriously ill or died, directly or indirectly as a result of their work on bioddefense projects, few of which have a public health mission," write the blog editors, who publish under the name Revere. "Piping money to scientists to work on dangerous bugs has a purpose if it is done in a measured way, with foresight and prudence."

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.